Azelastine Hydrochloride
Pricing Report NDC 51525-0234-3

Latest NADAC: $0.75083 per ML · Effective Aug 18, 2021
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Azelastine Hydrochloride (NDC 51525-0234-3) is $0.75083 per ML. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Aug 18, 2021.

As a provided by Wallace Pharmaceuticals Inc., this medication is distributed in a 1 BOTTLE in 1 CARTON / 200 SPRAY, METERED in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.75083
Per ML

Pricing Unit
Per ML Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Aug 18, 2021
Data Status
As of Aug 18, 2021
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
51525-0234-3
Description
1 BOTTLE in 1 CARTON / 200 SPRAY, METERED in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since May 2015, the NADAC wholesale price for (NDC ) has moved within a range of $0.75083 to $3.62437 per ML. Over this 6 years and 2 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.7508 - $3.6244
Market Volatility
382.72% Variance
Latest Trend
11.10%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Aug 18, 2021 $0.75083 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jul 21, 2021 $0.84460 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jun 23, 2021 $0.76254 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
May 19, 2021 $0.86630 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Apr 21, 2021 $0.89580 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Mar 17, 2021 $0.78539 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Feb 17, 2021 $0.76920 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jan 20, 2021 $0.84368 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Dec 23, 2020 $0.86196 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Nov 18, 2020 $0.99163 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Oct 21, 2020 $0.84531 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Sep 23, 2020 $0.95783 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026